Solid Biosciences (SLDB) PT Raised to $10 at Nomura/Instinet Dec 18, 2019 12:47PM
Solid Biosciences (SLDB) PT Lowered to $5 at Nomura/Instinet on IGNITE-DMD Clinical Hold Nov 13, 2019 06:21AM
Solid Biosciences (SLDB) Should Melt Up Into Next Update, PT To $22 At Nomura Feb 8, 2019 06:39AM
Nomura/Instinet Reiterates Buy on Solid Biosciences (SLDB) After Meeting with Management Dec 24, 2018 07:01AM
Solid Biosciences (SLDB) Should Benefit As Second Source In DMD, PT To $57 - Nomura Jun 25, 2018 06:58AM


Jun 25, 2018 06:20AM Solid Biosciences (SLDB) PT Raised to $57 at Nomura/Instinet
Mar 15, 2018 08:10AM Solid Biosciences (SLDB) PT Lowered to $37 at Nomura/Instinet Following Announced Clinical Hold
Feb 20, 2018 02:08AM Nomura/Instinet Starts Solid Biosciences (SLDB) at Buy
Jan 30, 2018 04:05PM Solid Biosciences Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Overallotment Option
Jan 26, 2018 11:35AM Solid Biosciences (SLDB) IPO Opens Up 59%
Jan 26, 2018 05:42AM Solid Biosciences Inc. (SLDB) Prices 7.81M Share IPO Offering at $16/Sh
Jan 25, 2018 06:56PM Solid Biosciences Announces Pricing of Initial Public Offering
Dec 29, 2017 03:44PM Solid Biosciences Files $100M NASDAQ IPO; Plans to List Under Ticker 'SLDB'